Bloomberg Philanthropies Commits $10 Million to Fight Opioid Crisis in Pennsylvania
December 03, 2018
Bloomberg Philanthropies announced a $50 million commitment to help combat the U.S. opioid epidemic. This commitment will be in partnership with Vital Strategies, The Pew Charitable Trust, Johns Hopkins University, and the Centers for Disease Control and Prevention. The initiative is reported to fund programs in up to ten states, with each state receiving funds during three years. Pennsylvania is the first state slated to receive funding, in an amount of $10 million.
During his November keynote speech at The Bloomberg American Health Summit in Washington, D.C., Michael Bloomberg said, “Today we are launching a groundbreaking new partnership with state and local leaders that aims to expand treatment for those who need it and save lives. We hope our work in Pennsylvania—one of the hardest hit states in the nation—will lay the groundwork for more effective action across the country.”
Details of Pennsylvania’s $10 million award have not been made public. Although, comments by Bloomberg seem to indicate that states will have significant discretion to implement programs and interventions. The multi-stakeholder partnership also is intended to provide technical assistance by “embedding staff” into state agencies.
Dr. Michael J. Consuelos, HAP’s senior vice president, clinical integration said, “There is no single solution to the opioid epidemic. The announcement that Michael Bloomberg will commit $10 million dollars to Pennsylvania efforts demonstrates how private-public partnerships could become force multipliers. While Pennsylvania has many initiatives underway, HAP applauds Bloomberg Philanthropies’ focus on funding local interventions and leveraging their partner’s expertise to help bring new, innovative interventions to the opioid epidemic.”
If you have questions, contact Dr. Michael J. Consuelos, HAP’s senior vice president, clinical integration.